Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.
Expand your knowledge & discuss future priorities in:
– Discovery & Development: Cell Therapies & Antibody Approaches
– Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology
– Discovery & Development: Intra-tumoral Immuno & Combination Therapies & Small Molecules as IO Therapies
– Translational & Preclinical and Clinical Development
View the agenda here – https://www.oxfordglobal.co.uk/immuno-series-us/agenda/?utm_source=ASCB&utm_medium=eventlisting&utm_campaign=immuno&utm_content=immunous2023
Co-located with Biomarkers US 2023 attendees receive access to both events. For more information contact firstname.lastname@example.org